Rallybio Corp

1
NAS:RLYB (USA)  
$ 1.30 -0.09 (-6.47%) 11:09 PM EST
At Loss
P/B:
0.55
Market Cap:
$ 53.88M
Enterprise V:
$ -36.14M
Volume:
79.57K
Avg Vol (2M):
274.45K
Trade In:
Volume:
79.57K
At Loss
Avg Vol (2M):
274.45K

Business Description

Description
Rallybio Corp is a clinical stage biotechnology company committed to identifying and accelerating the development of life-transforming therapies for patients with severe and rare disorders. Its program is for the prevention of fetal and neonatal alloimmune thrombocytopenia, a potentially life-threatening rare disease that can cause uncontrolled bleeding in fetuses and newborns.
Name Current Vs Industry Vs History
Cash-To-Debt 277.8
Equity-to-Asset 0.9
Interest Coverage N/A
N/A
N/A
Piotroski F-Score 3/9
0
1
2
3
4
5
6
7
8
9
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 39.14
9-Day RSI 42.58
14-Day RSI 43.29
6-1 Month Momentum % -8.5
12-1 Month Momentum % -76.23

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 9.77
Quick Ratio 9.77
Cash Ratio 9.34

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -19.4
Shareholder Yield % 0.28

Financials (Next Earnings Date:2024-08-08 Est.)

RLYB's 30-Y Financials
Income Statement Breakdown FY
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:RLYB

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Rallybio Corp Executives

Details

GF Value

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $)
EPS (TTM) ($) -1.872
Beta -1.69
Volatility % 121.04
14-Day RSI 43.29
14-Day ATR ($) 0.115369
20-Day SMA ($) 1.376
12-1 Month Momentum % -76.23
52-Week Range ($) 1.155 - 6.38
Shares Outstanding (Mil) 41.45

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 3
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Rallybio Corp Filings

Filing Date Document Date Form
No Filing Data

Rallybio Corp Stock Events

Financials Calendars
Event Date Price($)
No Event Data

Rallybio Corp Frequently Asked Questions

What is Rallybio Corp(RLYB)'s stock price today?
The current price of RLYB is $1.30. The 52 week high of RLYB is $6.38 and 52 week low is $1.16.
When is next earnings date of Rallybio Corp(RLYB)?
The next earnings date of Rallybio Corp(RLYB) is 2024-08-08 Est..
Does Rallybio Corp(RLYB) pay dividends? If so, how much?
Rallybio Corp(RLYB) does not pay dividend.

Press Release

Subject Date
No Press Release

Headlines

See More
  • 1
No news.
  • 1